Introducing FDI, the Florey Dementia Index for Alzheimer's onset prediction
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Dementia risk may be twice as high as Americans live longer, study finds
Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...
Aging for Amateurs: There are ways to limit your risk of dementia. Here are suggestions
The number of people diagnosed with dementia is skyrocketing worldwide. But treating even common health issues like high ...
Irish Examiner on MSN6 天
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Testing for dementia by asking patients to draw a clock, walk and talk, stand on one leg
Is it dementia? A popular neurologist uses five simple tests of cognitive function to help gauge the health of a patient's ...
Dementia risk is rising in an aging US population. Cases are projected to double by 2060
New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
Medscape4 天
Dementia Risk Higher for Stroke Survivors
Dementia risk is nearly 80% higher in stroke survivors than in those without stroke, with risk declining within 1 year but ...
manilatimes5 天
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to ...
China Medical System Holdings Limited (the 'Company”, together with its subsidiaries, the 'Group” or 'CMS”) is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary ...
FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
What Type of Doctor Treats Dementia and Cognitive Decline?
If you or a loved one is showing potential signs of age-related cognitive decline or dementia, you may want to seek help but not know the right type of health care provider to choose. That' ...